Read the latest news and research breakthroughs happening at the BC Cancer Agency

“I speak about cancer. I ride my bike. I do these things because I want to change the story. I want a different ending.”
In 2008, Patrick Sullivan lost his young son Finn to an extremely rare form of cancer, rhabdomyosarcoma. A few months later, he was approached by two close friends: “They told me about this fundraising bike ride to Seattle, the Ride to Conquer Cancer. They wanted to put a team in it – and do it in honour of Finn. That was the start of Team Finn.”
Every member of Team Finn is inspired by a little boy who lived every moment of his short life to the fullest. Their distinctive pink jerseys read “Run. Jump. Bounce. Dance. Sing. Love. Smile. Ride,” words that celebrate Finn’s approach to every day.
Finn showed how to live life with courage and joy, and his example has helped Team Finn achieve extraordinary success in raising funds for the BC Cancer Foundation. In just three years, they have raised over $1 million to support cancer research. As Finn’s father says, “Doctors couldn’t change Finn’s story. ‘Incurable’ was his ending. If I could change that for somebody else, then every moment of time is worth it.”

flyout blocks
flyout blocks
Your donations support innovative cancer research and compassionate enhancements to patient care.
flyout blocks
Participate or donate to a fundraising event to support breakthrough cancer research in BC.
flyout blocks
See how your donations are being used to enable the great work at the BC Cancer Agency to continue.
You are here
Scientists target enzyme and halt spread of deadly breast cancer tumours with novel drugs
Researchers at the BC Cancer Agency discover a significant connection between the spread of breast cancer and a natural enzyme, called CA9. This discovery proves CA9 is a major target in tumour survival and growth in over 50 per cent of the deadliest forms of breast cancer and 16 per cent of all breast cancers – researchers can now halt the spread of these tumours through the use of novel drugs.







